Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Herzog, C.
  • Schmitz, M.
  • Levkau, B.
  • Herrgott, I.
  • Mersmann, J.
  • Larmann, J.
  • Johanning, K.
  • Winterhalter, M.
  • Chun, Jerold
  • Muller, F. U.
  • Echtermeyer, F.
  • Hildebrand, R.
  • Theilmeier, G.

publication date

  • 2010

journal

  • Mediators of Inflammation  Journal

abstract

  • HDL, through sphingosine-1-phosphate (S1P), exerts direct cardioprotective effects on ischemic myocardium. It remains unclear whether other HDL-associated sphingophospholipids have similar effects. We therefore examined if HDL-associated sphingosylphosphorylcholine (SPC) reduces infarct size in a mouse model of transient myocardial ischemia/reperfusion. Intravenously administered SPC dose-dependently reduced infarct size after 30 minutes of myocardial ischemia and 24 hours reperfusion compared to controls. Infarct size was also reduced by postischemic, therapeutical administration of SPC. Immunohistochemistry revealed reduced polymorphonuclear neutrophil recruitment to the infarcted area after SPC treatment, and apoptosis was attenuated as measured by TUNEL. In vitro, SPC inhibited leukocyte adhesion to TNFα-activated endothelial cells and protected rat neonatal cardiomyocytes from apoptosis. S1P₃ was identified as the lysophospholipid receptor mediating the cardioprotection by SPC, since its effect was completely absent in S1P₃-deficient mice. We conclude that HDL-associated SPC directly protects against myocardial reperfusion injury in vivo via the S1P₃ receptor.

subject areas

  • Animals
  • Cardiotonic Agents
  • Dose-Response Relationship, Drug
  • Heart
  • Humans
  • Lipoproteins, HDL
  • Lysophospholipids
  • Mice
  • Mice, Inbred C57BL
  • Myocardial Ischemia
  • Myocardial Reperfusion Injury
  • Myocardium
  • Myocytes, Cardiac
  • Phosphorylcholine
  • Rats
  • Sphingosine
scroll to property group menus

Identity

PubMed Central ID

  • PMC3022218

International Standard Serial Number (ISSN)

  • 0962-9351

Digital Object Identifier (DOI)

  • 10.1155/2010/425191

PubMed ID

  • 21274265
scroll to property group menus

Additional Document Info

start page

  • 425191

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support